TITAN PHARMACEUTICALS INC·4

Mar 27, 9:45 AM ET

Choong Choon Hau 4

4 · TITAN PHARMACEUTICALS INC · Filed Mar 27, 2024

Insider Transaction Report

Form 4
Period: 2024-03-18
Transactions
  • Conversion

    Convertible Promissory Note

    2024-03-180 total
    Exercise: $9.32From: 2024-01-01Exp: 2024-01-01Common Stock (54,132 underlying)
  • Conversion

    Common Stock

    2024-03-18+54,1323,802,100 total
Footnotes (1)
  • [F1]On March 18, 2024, the Reporting Person converted an aggregate of $500,000 of the outstanding principal and $6,444.44 of the outstanding accrued interest, including $1,933.33 of tax withholding on interest earned, for a total sum payable of $504,501.11 under the Convertible Promissory Note issued by Issuer dated August 8, 2023. After giving effect to the conversion, as of the date of this Form 4, there are no outstanding in principal or in accrued interest outstanding under the Convertible Promissory Note.

Documents

1 file
  • 4
    ownership.xmlPrimary